Innoviva (INVA)

• Market cap: $1.49B
• 1 day: -1.09%
• 5 days: -4.46%
• 1 month: -9.33%
• 3 months: 3%
• 6 months: -8.62%
• Year to date: 14.48%
• 1 year: 8.14%
• 5 years: 64.49%
• 10 years: 87.75%
• Sector: Healthcare
• Industry: Biotechnology

About: Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.

Employees: 127